Effect of Bromfenac on Pain Related to Pterygium Surgery
Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution (bromfenac) 0.1%
dosed twice daily for the treatment of ocular inflammation and pain after pterygium excision
with amniotic membrane transplantation(AMT).
Phase:
Phase 4
Details
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University